Cyclobenzaprine Hydrochloride Tablets, USP, 10 mg, 90-count bottle, RX only, Manufactured by: ...

FDA Recall #D-0655-2025 — Class I — August 27, 2025

Recall #D-0655-2025 Date: August 27, 2025 Classification: Class I Status: Ongoing

Product Description

Cyclobenzaprine Hydrochloride Tablets, USP, 10 mg, 90-count bottle, RX only, Manufactured by: Unichem Laboratories, Ltd, Pilerne Ind. Estate, Pilerne, Bardez, Goa, India; Manufactured for: Unichem Pharmaceuticals (USA), Inc. East Brunswick, NJ. NDC 29300-415-19.

Reason for Recall

Labeling: Label Mix Up; Bottles of Meloxicam USP, 7.5mg, 90-count tablets (yellow in color), were labeled as Cyclobenzaprine Hydrochloride Tablets USP, 10 mg 90-count tablets (blue in color).

Recalling Firm

Unichem Pharmaceuticals USA Inc. — East Brunswick, NJ

Classification

Class I — Reasonable probability of serious adverse health consequences or death.

Product Type

Drugs

Product Quantity

230 90-count bottles

Distribution

Nationwide within the U.S.A

Code Information

Lot No: GMML24026A, Expires: 09/30/2027

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated